NASDAQ:GBIO Generation Bio (GBIO) Stock Price, News & Analysis $2.48 +0.10 (+4.20%) (As of 10/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Generation Bio Stock (NASDAQ:GBIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Generation Bio alerts:Sign Up Key Stats Today's Range$2.37▼$2.5150-Day Range$2.17▼$3.3452-Week Range$0.86▼$4.65Volume86,948 shsAverage Volume190,756 shsMarket Capitalization$164.99 millionP/E RatioN/ADividend YieldN/APrice Target$7.50Consensus RatingHold Company OverviewGeneration Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.Read More… How much money are you leaving on the table from the stocks you already own? (Ad)Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash flow. Simply put, this time-tested 3-step strategy allows anyone to create cash flow from the stocks you already own without selling a single share in your portfolio. I call it "The Cash Flow Trade", and my team is going to teach you how and when to execute it in this free live event.CLICK HERE TO RSVP Generation Bio Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks59th Percentile Overall ScoreGBIO MarketRank™: Generation Bio scored higher than 59% of companies evaluated by MarketBeat, and ranked 472nd out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingGeneration Bio has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGeneration Bio has only been the subject of 2 research reports in the past 90 days.Read more about Generation Bio's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Generation Bio are expected to grow in the coming year, from ($1.80) to ($0.91) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Generation Bio is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Generation Bio is -0.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGeneration Bio has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Generation Bio's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.39% of the float of Generation Bio has been sold short.Short Interest Ratio / Days to CoverGeneration Bio has a short interest ratio ("days to cover") of 18.3, which indicates bearish sentiment.Change versus previous monthShort interest in Generation Bio has recently increased by 13.83%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGeneration Bio does not currently pay a dividend.Dividend GrowthGeneration Bio does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.39% of the float of Generation Bio has been sold short.Short Interest Ratio / Days to CoverGeneration Bio has a short interest ratio ("days to cover") of 18.3, which indicates bearish sentiment.Change versus previous monthShort interest in Generation Bio has recently increased by 13.83%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News Sentiment0.73 News SentimentGeneration Bio has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Generation Bio this week, compared to 1 article on an average week. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Generation Bio insiders have not sold or bought any company stock.Percentage Held by Insiders21.10% of the stock of Generation Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.22% of the stock of Generation Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Generation Bio's insider trading history. Receive GBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Generation Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address GBIO Stock News HeadlinesGeneration Bio Co. (GBIO)October 2, 2024 | finance.yahoo.comShort Interest in Generation Bio Co. (NASDAQ:GBIO) Increases By 13.8%October 1, 2024 | americanbankingnews.comWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …October 6, 2024 | Weiss Ratings (Ad)Generation Bio to Present at the 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comRunway's Gen-3 Turbo AI video generator just got a big upgrade — here’s what’s newAugust 22, 2024 | msn.comGeneration Bio Co. (NASDAQ:GBIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesAugust 10, 2024 | finance.yahoo.comBuy Rating Affirmed for Generation Bio on Strong Financials and Technological AdvancementsAugust 9, 2024 | markets.businessinsider.comThe bra trend Gen Z are ditching fast — and it’s not what you thinkAugust 7, 2024 | nypost.comSee More Headlines GBIO Stock Analysis - Frequently Asked Questions How have GBIO shares performed this year? Generation Bio's stock was trading at $1.65 at the beginning of the year. Since then, GBIO stock has increased by 50.3% and is now trading at $2.48. View the best growth stocks for 2024 here. How were Generation Bio's earnings last quarter? Generation Bio Co. (NASDAQ:GBIO) posted its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.04. The company earned $4.09 million during the quarter, compared to analysts' expectations of $3.23 million. Generation Bio had a negative trailing twelve-month return on equity of 92.86% and a negative net margin of 1,202.56%. When did Generation Bio IPO? Generation Bio (GBIO) raised $126 million in an initial public offering on Friday, June 12th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen acted as the underwriters for the IPO and Wedbush PacGrow was co-manager. Who are Generation Bio's major shareholders? Top institutional investors of Generation Bio include SG Americas Securities LLC (0.03%). Insiders that own company stock include Phillip Samayoa, Antoinette Paone, Dannielle Appelhans and Donald William Nicholson. View institutional ownership trends. How do I buy shares of Generation Bio? Shares of GBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Generation Bio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Generation Bio investors own include DocuSign (DOCU), NVIDIA (NVDA), Overstock.com (OSTK), Boeing (BA), Pure Storage (PSTG), Mastercard (MA) and QUALCOMM (QCOM). Company Calendar Last Earnings8/07/2024Today10/05/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:GBIO CUSIPN/A CIK1733294 Webgenerationbio.com Phone617-655-7500FaxN/AEmployees150Year FoundedN/APrice Target and Rating Average Stock Price Target$7.50 High Stock Price Target$10.00 Low Stock Price Target$5.00 Potential Upside/Downside+202.4%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($2.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-126,610,000.00 Net Margins-1,202.56% Pretax Margin-1,202.56% Return on Equity-92.86% Return on Assets-48.47% Debt Debt-to-Equity RatioN/A Current Ratio7.42 Quick Ratio7.42 Sales & Book Value Annual Sales$13.17 million Price / Sales12.52 Cash FlowN/A Price / Cash FlowN/A Book Value$3.07 per share Price / Book0.81Miscellaneous Outstanding Shares66,529,000Free Float52,491,000Market Cap$164.99 million OptionableOptionable Beta2.81 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:GBIO) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredAI expert reveals new Nvidia predictionEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.